Introduction {#sec1-1}
============

Breast cancer is the second most common cancer in the world and the most frequent cancer among women with an estimated 1.67 million new cancer cases diagnosed in 2012 (25% of all cancers). It is more common in the more developed Western countries than in Africa, South America and Asia. Incidence rate ranges from 27 per 100,000 in Middle Africa and Eastern Asia to 96 in Western Europe. Breast cancer ranks as the fifth cause of death from cancer overall (522,000 deaths) and while it is the most frequent cause of cancer death in women in less developed regions (324,000 deaths, 14.3% of total), it is now the second cause of cancer death after lung cancer in more developed regions (198,000 deaths,15.4%). The range in mortality rates between world regions is less than that for incidence because of the more favourable survival from breast cancer in (high-incidence) developed regions (Ferlay *et al.*, 2015). In Western Libya, breast cancer comprised the commonest type of tumors in females and contributes to 33% of all female cancer (Abussa, 2007) while it ranged from 23% (El Mistiri *et al.*, 2007) to 37.4% (Bodalal *et al.*, 2014) in Eastern Libya.

Several factors have been implicated in the pathogenesis of breast cancers. These included some primary risk factors including sex and age in addition to other potential risk factors like genetics, family history, diet, alcohol, obesity, lack of breastfeeding as well as disturbances in certain hormones. Other contributing factors are mammographic density and previous benign disease (Dabbs, 2012). However, any factor predominance has not yet been determined (Abdulkareem, 2013). Immuno- histochemical studies of breast cancer emerged during the 1980s (Hsu *et al.*, 1981) and since then, many types of specific and nonspecific glycoprotein molecular markers have been specified and located. These tissue markers were essential for the assessment of neoplastic existence, aggressiveness and prognosis (Haga *et al.*, 1991; Callahan, 1992; Press *et al.*, 1997; Lichtenbeld *et al.*, 1998).

Research work concerning human mammary neoplasia and other related issues has largely been dependent on mouse models and cell lines. However, the proximity between canine and human species has encouraged scientist to introduce dogs as an alternative model for comparative cancer research projects. Hawai *et al*. (2013) and Sultan and Ganaie (2018) have reviewed many factors in favor of adopting dogs. These included a homologous genome sequence, genetic diversity, spontaneous growth of tumors, common living environment and many others. Queiroga *et al*. (2011), Mol (2013) and Carvalho *et al*. (2016) have also mentioned the existence of similar pathways involved in tumorigenesis, common tissue markers with close immunohistochemical analysis along with similar role of inflammatory cells in tumor microenvironment. Comparative investigations concerning mammary tumor morphology and taxonomy in dogs and human have been continual over the last few decades (Nerurkar *et al.*, 1989; Sorenmo *et al.*, 2009; Cassali, 2013). Promoting studies however, are essential in supporting available information in order to elucidate ambiguities in the nature, versions and behavior of canine mammary tumors. Such research projects would facilitate adopting dogs as an ideal experimental model

Materials and Methods {#sec1-2}
=====================

Specimens of forty four (44) canine mammary tumors and 70 breast tumors were embodied in this study. The canine samples belonged to 30 female dogs and were collected from the departmental stock (Department of Pathology, Faculty of Veterinary Medicine, University of Tripoli) and from cases admitted to the faculty over the period of conducting this study. The human samples on the other hand, consisted of stained tissue sections of breast tumors prepared by the "Central Pathology Laboratory" at Tripoli Medical Center (TMC). The last 70 cases registered in 2013 were selected to insure random sampling.

All specimens were stained with H&E and some were immunostained for ER, HER-2 and Ki-67 by Peroxidase-antiperoxidase (PAP) method. Immunostaining was carried by Ventana BenchMarkXT Automated Staining System using Ventana monoclonal primary antibodies ready to use for ER (Mouse monoclonal antibodies, clone SP1), HER-2 (Rabbit monoclonal antibodies, clone 4B5) and Ki-67 (Rabbit monoclonal antibodies, clone 30-9) for 30 minutes. This was followed by incubation for 30 minutes with a ready-to-use secondary antibody (Dako REALTM EnVisionTM/Horseradish Peroxidase, Rabbit/Mouse) and with the substrate Dako REALTM Diaminobenzidine with Chromogen for a further 10 minutes.

Freshly collected canine mammary samples were fixed in 10% neutral buffered formalin (NBF) for 48hrs, dehydrated in ascending concentrations of Ethyl alcohol, cleared in xylol then dipped in paraffin wax. Sections of 5µm were mounted on frosted-end glass slides for staining with Hematoxyline and Eosin (H&E) (Lillie, 1965) and on charged slides for immune-staining of ER, Ki67 and HER-2. The later was carried out by "Leica Microsystems Bond MAX System" (Leica Microsystems) and sections of different types of tumor and best sectional quality were selected. Sections were incubated in 72°C and treated with Bond Dewax Solution (Leica Microsystems). Epitope retrieval was performed by incubating the slides in Bond Epitope Retrieval Solution 1 (Citrate based pH 6.0 solution) for ER and Ki67, and Bond Epitope Retrieval Solution 2 (EDTA based pH 9.0 solutions) for HER2 for 20 minutes at 100°C. Sections were then blocked for endogenous Peroxidase in 3% hydrogen peroxide for 5 minutes and were incubated with primary antibodies of ER (Clone 6F11, Novocastra laboratories), HER-2 (Clone CB11, Novocastra laboratories) and Ki-67 (Clone MM1, Novocastra laboratories) for 15 minutes at room temperature. Primary antibodies were monoclonal mouse anti-human and were used at a dilution of 1:50, 1:700 and 1:200 respectively. Post Primary Polymer (Leica Microsystems) was applied for 8 minutes followed by Polymer Poly-Horseradish Peroxidase (Leica Microsystems) for another 8 minutes then Diaminobenzidine chromogen (DAB) for 10 minutes.

Sections were counterstained for 10 minutes. Wash solution and de-ionized water were used between the main steps (Qiu *et al.*, 2010). Specimens of human invasive ductal carcinoma were adopted as positive control. Specific staining of any intensity was considered positive. Canine tumors were classified according to Goldschmidt *et al*. (2011) while human tumors according to WHO adopted classification of Tavassoli and Devilee (2003).

Results {#sec1-3}
=======

Examination of the canine specimens revealed the existence of a majority of malignant over benign conditions (95.5% : 4.5%) of which, carcinomas were predominant. Specimens of benign tumors included a case of mixed mammary tumor and a glandular hyperplasia ([Table 1](#T1){ref-type="table"}).

###### 

Types, number and ratio of canine mammary tumors.

  Types                                             No.   \%
  ------------------------------------------------- ----- ------
  Malignant tumors                                  42    95.5
  Complex carcinoma                                 7     16.7
  Tubular carcinoma                                 7     16.7
  Cystic papillary carcinoma                        6     14.3
  Malignant mixed mammary tumors                    5     11.9
  Invasive micropapillary carcinoma                 3     7.1
  Solid carcinoma                                   3     7.1
  Carcinoma and malignant myoepithelioma            3     7.1
  Fibrosarcoma                                      3     7.1
  Tubulopapillary carcinoma                         2     4.8
  Carcinoma arising in benign mixed mammary tumor   2     4.8
  Mucinous carcinoma                                1     2.4
  Benign tumors                                     2     4.5
  Benign mixed mammary tumor                        1     50
  Hyperplasia                                       1     50

Carcinomas were also predominant among human malignancies but the malignant to benign ratio was close (45.7% to 54.3%) ([Table 2](#T2){ref-type="table"}). Invasive ductal carcinoma (IDC) was most frequently diagnosed among other types of carcinoma (71%) while fibroadenoma constituted about (94%) of the benign tumors.

###### 

Types, number and ratio of human breast tumors.

  Types                               No.   \%
  ----------------------------------- ----- ------
  Malignant tumors                    38    54.3
  Invasive ductal carcinoma           27    71.1
  Ductal carcinoma in situ            3     7.9
  Inflammatory mammary carcinoma      2     5.3
  Invasive micropapillary carcinoma   2     5.3
  Invasive lobular carcinoma          1     2.6
  Mucinous carcinoma                  1     2.6
  Cribriform carcinoma                1     2.6
  Malignant Phyllodes tumor           1     2.6
  Benign tumors                       32    45.7
  Fibroadenoma                        30    93.8
  Intraductal Papilloma               1     3.1
  Benign Phyllodes                    1     3.1

Microscopic examination of tumor samples in canine and human specimens reflected the existence of a remarkable resemblance in the origin, distribution and behavior of neoplastic tissue. This was particularly obvious between 'simple tubular carcinoma' in dogs and 'invasive ductal carcinoma' in human in which epithelial neoplastic cells accumulate and break through the walls of the glandular ductules into the surrounding stroma ([Fig. 1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}). Individual and clustered neoplastic cells usually elicit desmoplastic reaction and often invade nearby lymphatics. Other neoplastic forms have also demonstrated similar orientation as in comedo-carcinoma when the center of cellular clusters whether in or out of ductules undergo necrosis and dissolution ([Fig. 1C](#F1){ref-type="fig"} and [1D](#F1){ref-type="fig"}). Mucinous carcinoma characterized by mucin-secreting neoplastic cells and mucin-filled cavities were also demonstrated in canine and human specimens ([Fig. 1E](#F1){ref-type="fig"} and [1F](#F1){ref-type="fig"}).

![**(A and B)**: Invasive carcinoma: Infiltration of individual and clumps of malignant cells in the stroma (100x). **(C and D)**: Comedo-carcinoma: Intraductular dissociation and accumulation of necrotic epithelium (400x). **(E and F)**: Mucinous carcinoma: Profuse mucin secreting neoplastic epithelium (200x). **(G and H)**: Invasive micropapillary carcinoma: neoplastic cellular papillae arising from lining epithelium (G: 200x; H: 400x). **(I and J)**: Carcinoma with squamous metaplasia (200x). **(K and L)**: Chondroid differentiation in the stroma (K: 400x; L: 200x). **(M and N)**: Fibrosarcoma: Criss-crossing bundles of intense fibroplasia (200x) (Stain: H&E). (A, C, E, G, I, K, M = Canine). (B, D, F, H, J, L, N = Human).](OpenVetJ-8-243-g001){#F1}

The highly invasive micro-papillary carcinoma characterized by small cellular papillae arising from ductular lining epithelium were also noticed in both human and canine specimens ([Fig. 1G](#F1){ref-type="fig"} and [1H](#F1){ref-type="fig"}). Squamous metaplasia with the formation of loose nests is one of the transitional changes in carcinoma noticed in both species ([Fig. 1I](#F1){ref-type="fig"} and [1J](#F1){ref-type="fig"}).

Chondroid differentiation was noticed in mixed mammary tumor in canine and following metaplastic changes in human breast. Chondrosarcoma was recognized in a human specimen ([Fig. 1K](#F1){ref-type="fig"} and [1L](#F1){ref-type="fig"}) while fibrosarcoma was not un-common in both species ([Fig. 1M](#F1){ref-type="fig"} and [1N](#F1){ref-type="fig"}).

Immunohistochemical detection of specific hormonal marker receptors has also shown resemblance in some aspects. HER-2 ([Fig. 2C](#F2){ref-type="fig"} and [2D](#F2){ref-type="fig"}) and Ki-67 ([Fig. 2E](#F2){ref-type="fig"} and [2F](#F2){ref-type="fig"}) were demonstrated in comparable locations in the specimens of both species but ER active sites were not stainable in canine sections ([Fig. 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}).

![**(A)**: Negative nuclear ER staining. **(B)**: Positive nuclear ER staining. **(C and D)**: positive membranous staining of HER-2. **(E and F)**: Positive nuclear staining of Ki-67. (Stain: PAP, 400x). (A, C, E = Canine). (B, D, F = Human).](OpenVetJ-8-243-g002){#F2}

Lower ranges of 10-31% for malignant and 70-90% for benign however were found in the United States following three investigations which employed different methods of examination (Stavros *et al.*, 1995). IDC among other kinds of carcinoma has also represented a majority in breast cancer in this study while fibroadenoma was predominant in the benign group.

Discussion {#sec1-4}
==========

The present investigation included 44 canine specimens taken from 30 bitches with single and Multicentric (Multiple) mammary tumors. These specimens were collected from different breeds among which, Mixed breed, German Shepherd and Yorkshire Terrier were predominant. These breeds of dogs were also found to possess high incidence of mammary tumors in other studies (Gupta *et al.*, 2012).

The age predisposition in the current study ranged from 3-14 years. Age distribution however, was almost even and showed no predominance probably due to the small size of the sample. This wide range of age predisposition however, is in general agreement with other studies which estimated it at 4-15 years with a median of 8-10 years (Yang *et al.*, 2006; Morris *et al.*, 2009).

Malignant tumors constituted 41% and 53% by Misdorp *et al*. (1999) and Lana *et al*. (2007) respectively. In beagles however, malignant tumors constituted 34% in a survey carried on 4755 dogs (Benjamin *et al.*, 1999). They justified that level of existence to the late stage of tumor removal and/or to the high number of intact females as well as to the older age of spaying. The extremely high level of existence of malignancies in the current study which has mounted to 95.5% does not really reflect the actual situation.

Benign tumors in general, are not accurately registered probably because they are overlooked for their small un-palpable size or because they do not represent a real threat to the animals.

The medical history of most of our cases was deficient and did not provide sufficient information about spaying, number of intact females or medical attention. The small size of the sample and late recognition of tumors may also justify the higher existence of malignancy. The high incidence of carcinomas demonstrated in this sample agrees well with Misdorp *et al*. (1999) and Misdorp (2002) who recognized an overwhelming predominance of carcinomas over sarcomas and carcinosarcomas in dogs mammary gland.

On the other hand, the ratio of benign to malignant tumors in human breast agreed with those stated in India which ranged between 50.4% and 49.6% out of 252 specimen (Mudholkar *et al.*, 2012).

Involvement of more than one mammary gland in dogs is not uncommon and was reported in this study as well as in others (Misdorp *et al.*, 1999; Funakoshi *et al.*, 2000; Reddy *et al.*, 2009; Kumar *et al.*, 2010). Multicentric mammary tumors are usually an issue of older dogs which suffer from medical negligence. The existences of tumors which descend from different cells of origin in adjacent glands suggest an independent primary tumor growth. Such diversity in multicentric tumors was reported by others who demonstrated different combinations of mesenchymal as well as epithelial origin (Misdorp *et al.*, 1999; Funakoshi *et al.*, 2000; Reddy *et al.*, 2009; Kumar *et al.*, 2010). The existence of similar tumors in adjacent glands can result from spontaneous development or metastasis.

Bilateral breast cancers were not recorded in this study but were reported by Janschek *et al*. (2001) and Bassarova *et al*. (2005) who referred that to simultaneous or following metastasis from contralateral gland. The generation of microvascular channels which promote metastasis by malignant tumor cells 'Endothelial-like cells' (ELCs) without endothelial cell participation has been reported in human and canine mammary cancers (Clemente *et al.*, 2010).

The existence in this study of canine mammary tumors possessing histological features that belong to more than one subtype is a matter of controversy. Misdorp *et al*. (1999) and Goldschmidt *et al*. (2011), listed these subtypes as an independent entity. Others, (Benjamin *et al.*, 1999) however, have pointed out to the possibility of transition from one kind into another, such as transition of solid carcinoma into papillary or comedo-carcinoma. On the other hand, Moulton *et al*. (1970) have demonstrated an adverse kind of transition in which papillary or lobular carcinoma are turned into solid carcinoma. Transition was also reported in human breast tumors and is thought to be stimulated by the frequency of cell proliferation, apoptosis and necrosis (Boghaert *et al.*, 2014).

In the current study, the main aspect in comparison between canine and human mammary gland tumors is the morphological orientation of neoplastic cells. Cells of origin, cell configuration and transitional forms were comparable in the specimens of both species despite differences in terminology. Sinn and Kreipe (2013) taxonomy which is adopted by the WHO has included Solid, Cribriform and Papillary cellular orientation as transitional forms of invasive carcinoma of 'No Special Type' (NST). In canine on the other hand, these forms are considered as independent entities by latest taxonomies (Misdorp *et al.*, 1999; Goldschmidt *et al.*, 2011). Other kinds of tumors including Mucinous carcinoma, Invasive micropapillary carcinoma and comedo-carcinoma possess similar morphology and terminology in both species.

Mixed mammary tumors in dogs comprised of mesenchymal and epithelial components have their counterpart in humans. In dogs, these tumors can be benign when bone and/or cartilage components are metaplastic or considered malignant when these elements carry malignant features. In human, this form is permanently metaplastic (Metaplastic carcinoma) except for phyllodes in which malignant mesenchymal differentiation exist. Inflammatory carcinoma and invasive cribriform carcinoma which were diagnosed in our human specimens have also their counterpart in canine although they were not noticed in our samples.

The localization of HER-2 and Ki-67 markers at similar sites in the mammary tissue of both species indicate the existence of common aspects in immunohistochemical characteristics. These findings are in accordance with previous information about the existence of such markers in canine and the variation in their intensity (Nowak *et al.*, 2005; Joensuu *et al.*, 2013; Peña *et al.*, 2014; Zaha, 2014). The remarkable absence of ER staining is not well understood, but Peña *et al*. (2014) justified that on the basis of delayed or inadequate fixation, usage of different monoclonal antibodies raised against human ER or due to the application of different heat antigen retrieval protocols. Qiu *et al*. (2010), found an inverse correlation between prolonged formalin fixation and intensity of ER receptors expression while others (Webster *et al.*, 2009), suggest that prolonged formalin fixation has minimal effects on antigen detection for most commonly used antibodies. Our attempts have not succeeded despite several attempts with short and prolonged fixation periods. ER, HER-2 and Ki-67 were particularly chosen for their availability and for being in current use in research and for medical purposes.

This investigation declared an encouraging degree of resemblance between certain tumors in human and canine. These tumors were found similar in different ways including their cellular origin, morphology, behavior and some markers localization. These findings add additional support for previous investigations in the same field which aim at introducing dogs as an ideal experimental model for studying mammary tumors in human.
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